Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study)

NCT ID: NCT01454947

Last Updated: 2024-05-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

248 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-08-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the development of resistant strains. Though providers are adequately trained to know when antibiotics are and are not comparatively effective, this has not been sufficient to affect critical provider practices.

The intent of this study is to apply behavioral economic theory to reduce the rate of antibiotic prescriptions for acute respiratory diagnoses for which guidelines do not call for antibiotics. Specifically targeted are infections that are likely to be viral.

The objective of this study is to improve provider decisions around treatment of acute respiratory infections.

The participants are practicing attending physicians or advanced practice nurses (i.e. providers) at participating clinics who see acute respiratory infection patients. A maximum of 550 participants will be recruited for this study.

Providers consenting to participate will fill out a baseline questionnaire online. Subsequent to baseline data collection and enrollment, participating clinic sites will be randomized to the study arms, as described below.

There will be a control arm, with clinic sites randomized in a multifactorial design to up to three interventions that leverage the electronic medical record: Order Sets that are triggered by electronic health record (EHR) workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives); Accountable Justifications triggered by discordant prescriptions that populate the note with provider's rationale for guideline exceptions (AJ); and performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparisons).

The outcomes of interest are antibiotic prescribing patterns, including prescribing rates and changes in prescribing rates over time.

The intervention period will be over one year, with a one-year follow up period to measure persistence of the effect after EHR features are returned to the original state and providers no longer receive email alerts.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each consented provider will be randomized to 1 of 8 cells in a factorial design with equal probability. If results of retrospective data analysis imply that design will be improved by stratification, randomization will be stratified by factors that could influence outcomes.

Data will be collected from the clinics' Enterprise Data Warehouses which store copies of data recorded in the electronic health record. Data elements from qualifying office visits will be collected from coded portions of the electronic health record.

An encounter is eligible for intervention if the patient's diagnosis is in the selected group of acute respiratory infections. The intervention EHR functions will be triggered when clinicians initiate an antibiotic prescription or enter a diagnosis for an acute respiratory infection that has a defined Order Set. If an antibiotic from a list of frequently misprescribed antibiotics is ordered and a diagnosis has not yet been entered, providers will be prompted to enter a diagnosis. If the diagnosis entered is acute nasopharyngitis; acute laryngopharyngitis/acute upper respiratory infection; acute bronchitis; bronchitis not specified as acute or chronic; or flu; the interventions will be triggered. The diagnosis-appropriate order set will pop-up for providers in the SA arm, while clinicians randomized to the AJ arm will receive an alert and be required to enter a brief statement justifying their antibiotic prescription if antibiotics are not indicated for the diagnosis entered. This note will then be added to the patient's medical record.

Clinicians randomized to the Peer Comparison condition will receive email updates about their antibiotic prescribing practices relative to other clinicians in their practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Infections (ARIs)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SA, AJ, PC

Participants are given all 3 interventions.

Group Type EXPERIMENTAL

Clinical Decision Support (CDS): Accountable Justifications

Intervention Type BEHAVIORAL

Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).

Audit and Feedback: Peer Comparison

Intervention Type BEHAVIORAL

Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).

CDS Order Sets: Suggested Alternatives

Intervention Type BEHAVIORAL

Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).

SA, AJ

Participants receive the Suggested Alternatives and Accountable Justification interventions, but not the Peer Comparison intervention.

Group Type EXPERIMENTAL

Clinical Decision Support (CDS): Accountable Justifications

Intervention Type BEHAVIORAL

Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).

CDS Order Sets: Suggested Alternatives

Intervention Type BEHAVIORAL

Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).

SA, PC

Participants receive the Suggested Alternative and Peer Comparison interventions, but not the Accountable Justification intervention.

Group Type EXPERIMENTAL

Audit and Feedback: Peer Comparison

Intervention Type BEHAVIORAL

Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).

CDS Order Sets: Suggested Alternatives

Intervention Type BEHAVIORAL

Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).

AJ, PC

Participants receive the Accountable Justification and Peer Comparison interventions, but not the Suggested Alternative intervention.

Group Type EXPERIMENTAL

Clinical Decision Support (CDS): Accountable Justifications

Intervention Type BEHAVIORAL

Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).

Audit and Feedback: Peer Comparison

Intervention Type BEHAVIORAL

Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).

Peer Comparison (PC)

Participants receive the Peer Comparison intervention, but do not receive the Suggested Alternatives or Accountable Justification interventions.

Group Type EXPERIMENTAL

Audit and Feedback: Peer Comparison

Intervention Type BEHAVIORAL

Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).

Suggested Alternatives (SA)

Participants receive the Suggested Alternatives intervention, but not the Accountable Justification or Peer Comparison interventions.

Group Type EXPERIMENTAL

CDS Order Sets: Suggested Alternatives

Intervention Type BEHAVIORAL

Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).

Accountable Justification (AJ)

Participants receive the Accountable Justification intervention, but do not receive the Suggested Alternatives or Peer Comparison interventions.

Group Type EXPERIMENTAL

Clinical Decision Support (CDS): Accountable Justifications

Intervention Type BEHAVIORAL

Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).

Education Control

Participants do not receive any of the 3 interventions.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clinical Decision Support (CDS): Accountable Justifications

Accountable Justifications triggered by discordant prescriptions that populate the electronic health record (EHR) note with provider's rationale for guideline exceptions (AJ).

Intervention Type BEHAVIORAL

Audit and Feedback: Peer Comparison

Performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison).

Intervention Type BEHAVIORAL

CDS Order Sets: Suggested Alternatives

Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives).

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AJ Accountable Justification PC Peer Comparison SA Suggested Alternatives

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A practicing attending physician or advanced practice nurse ("provider") at a participating clinic in 2011-2013 who sees acute respiratory infection patients.

Exclusion Criteria

* None.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

University of Southern California

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jason Doctor

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jason N Doctor, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Southern California

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Altamed Anaheim Lincoln

Anaheim, California, United States

Site Status

Altamed Anaheim West

Anaheim, California, United States

Site Status

Altamed Bell Clinic

Bell, California, United States

Site Status

Altamed Mobile Unit Primary Care

Commerce, California, United States

Site Status

Altamed DVL El Monte

El Monte, California, United States

Site Status

Altamed El Monte Clinic

El Monte, California, United States

Site Status

Altamed Garden Grove Harbor

Garden Grove, California, United States

Site Status

Altamed Huntington Beach Clinic

Huntington Beach, California, United States

Site Status

Altamed PACE Rugby

Huntington Park, California, United States

Site Status

The Children's Clinic Family Health Center at Cesar Chavez Elementary School

Long Beach, California, United States

Site Status

The Children's Clinic Family Health Center at Hamilton Middle School

Long Beach, California, United States

Site Status

The S. Mark Taper Foundation Children's Clinic Family Health Center

Long Beach, California, United States

Site Status

The Children's Clinic at the Long Beach Multi-Service Center for the Homeless

Long Beach, California, United States

Site Status

The Vasek Polak Children's Clinic Family Health Center

Long Beach, California, United States

Site Status

Altamed PACE Grand Plaza

Los Angeles, California, United States

Site Status

Altamed William Mead Homes

Los Angeles, California, United States

Site Status

Altamed Commerce Clinic

Los Angeles, California, United States

Site Status

Altamed DVL Commerce

Los Angeles, California, United States

Site Status

Altamed PACE Pomona

Los Angeles, California, United States

Site Status

Altamed Boyle Heights Clinic

Los Angeles, California, United States

Site Status

Altamed Estrada Courts

Los Angeles, California, United States

Site Status

Altamed Ramona Gardens

Los Angeles, California, United States

Site Status

AltaMed 1st St Boyle Heights Clinic

Los Angeles, California, United States

Site Status

Altamed Zonal Clinic

Los Angeles, California, United States

Site Status

Altamed Montebello Clinic

Montebello, California, United States

Site Status

Altamed El Modena Clinic

Orange, California, United States

Site Status

Altamed Pico Clinic

Pico Rivera, California, United States

Site Status

Altamed DVL Pico

Pico Rivera, California, United States

Site Status

Altamed Santa Ana Main

Santa Ana, California, United States

Site Status

Altamed Clinic For Women

Santa Ana, California, United States

Site Status

Altamed Santa Ana Broadway

Santa Ana, California, United States

Site Status

Altamed Santa Ana Central

Santa Ana, California, United States

Site Status

Brigham and Women's Primary Care Associates at Foxborough

Boston, Massachusetts, United States

Site Status

MGH Downtown

Boston, Massachusetts, United States

Site Status

Mass General Medial Group

Boston, Massachusetts, United States

Site Status

MGH Beacon Hill

Boston, Massachusetts, United States

Site Status

MGH Senior Health

Boston, Massachusetts, United States

Site Status

Women's Health Associates

Boston, Massachusetts, United States

Site Status

Brigham Circle Medical Associates

Boston, Massachusetts, United States

Site Status

Brigham Internal Medicine Associates

Boston, Massachusetts, United States

Site Status

Spanish Clinic

Boston, Massachusetts, United States

Site Status

MGH Back Bay

Boston, Massachusetts, United States

Site Status

Brigham and Women's Primary Care Associates of Brookline

Brookline, Massachusetts, United States

Site Status

MGH Charlestown HealthCare Center

Charlestown, Massachusetts, United States

Site Status

MGH Chelsea HealthCare Center

Chelsea, Massachusetts, United States

Site Status

Brigham and Women's Physician Group

Chestnut Hill, Massachusetts, United States

Site Status

Gretchen and Edward Fish Center for Women's Health

Chestnut Hill, Massachusetts, United States

Site Status

Everett Family Practice

Everett, Massachusetts, United States

Site Status

Brigham Primary Physicians at Faulkner

Jamaica Plain, Massachusetts, United States

Site Status

Brookside Community Health Center

Jamaica Plain, Massachusetts, United States

Site Status

Faulkner Community Physicians

Jamaica Plain, Massachusetts, United States

Site Status

Southern Jamaica Plain Health Center

Jamaica Plain, Massachusetts, United States

Site Status

Brigham and Women's Primary Care Associates of Newton Corner

Newton, Massachusetts, United States

Site Status

Mass General Revere HealthCare Center

Revere, Massachusetts, United States

Site Status

Mass General West Medical Group

Waltham, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016 Feb 9;315(6):562-70. doi: 10.1001/jama.2016.0275.

Reference Type BACKGROUND
PMID: 26864410 (View on PubMed)

Doctor JN, Goldstein NJ, Fox CR, Linder JA, Persell SD, Stewart EP, Knight TK, Meeker D. Clinician Job Satisfaction After Peer Comparison Feedback: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 Jun 1;6(6):e2317379. doi: 10.1001/jamanetworkopen.2023.17379.

Reference Type DERIVED
PMID: 37289454 (View on PubMed)

Gong CL, Zangwill KM, Hay JW, Meeker D, Doctor JN. Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis. J Gen Intern Med. 2019 Jun;34(6):846-854. doi: 10.1007/s11606-018-4467-x. Epub 2018 May 8.

Reference Type DERIVED
PMID: 29740788 (View on PubMed)

Gong CL, Hay JW, Meeker D, Doctor JN. Prescriber preferences for behavioural economics interventions to improve treatment of acute respiratory infections: a discrete choice experiment. BMJ Open. 2016 Sep 22;6(9):e012739. doi: 10.1136/bmjopen-2016-012739.

Reference Type DERIVED
PMID: 27660322 (View on PubMed)

Persell SD, Friedberg MW, Meeker D, Linder JA, Fox CR, Goldstein NJ, Shah PD, Knight TK, Doctor JN. Use of behavioral economics and social psychology to improve treatment of acute respiratory infections (BEARI): rationale and design of a cluster randomized controlled trial [1RC4AG039115-01]--study protocol and baseline practice and provider characteristics. BMC Infect Dis. 2013 Jun 27;13:290. doi: 10.1186/1471-2334-13-290.

Reference Type DERIVED
PMID: 23806017 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1RC4AG039115-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

1RC4AG039115-01

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Booster Incentives
NCT05648773 COMPLETED NA